{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:01:07Z","timestamp":1783472467573,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00213-014-3719-7","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T02:34:09Z","timestamp":1409625249000},"page":"815-824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats"],"prefix":"10.1007","volume":"232","author":[{"given":"Ahmad A.","family":"Altarifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"Selley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"3719_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/FBP.0b013e32834aff54","volume":"22","author":"AA Altarifi","year":"2011","unstructured":"Altarifi AA, Negus SS (2011) Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol 22:663\u2013673","journal-title":"Behav Pharmacol"},{"key":"3719_CR2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/FBP.0b013e328358593c","volume":"23","author":"AA Altarifi","year":"2012","unstructured":"Altarifi AA, Miller LL, Negus SS (2012) Role of mu-opioid receptor reserve and mu-agonist efficacy as determinants of the effects of micro-agonists on intracranial self-stimulation in rats. Behav Pharmacol 23:678\u2013692","journal-title":"Behav Pharmacol"},{"key":"3719_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FBP.0b013e328364c0bd","volume":"24","author":"AA Altarifi","year":"2013","unstructured":"Altarifi AA, Rice KC, Negus SS (2013) Abuse-related effects of mu-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure. Behav Pharmacol 24:459\u2013470","journal-title":"Behav Pharmacol"},{"key":"3719_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0376-8716(85)90060-2","volume":"14","author":"RL Balster","year":"1985","unstructured":"Balster RL, Lukas SE (1985) Review of self-administration. Drug Alcohol Depend 14:249\u2013261","journal-title":"Drug Alcohol Depend"},{"key":"3719_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.107.129023","volume":"324","author":"C Beguin","year":"2008","unstructured":"Beguin C, Potter DN, Dinieri JA, Munro TA, Richards MR, Paine TA, Berry L, Zhao Z, Roth BL, Xu W, Liu-Chen LY, Carlezon WA Jr, Cohen BM (2008) N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy. J Pharmacol Exp Ther 324:188\u2013195","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","volume":"271","author":"PJ Emmerson","year":"1994","unstructured":"Emmerson PJ, Liu MR, Woods JH, Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630\u20131637","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-3565(25)20761-3","volume":"278","author":"PJ Emmerson","year":"1996","unstructured":"Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther 278:1121\u20131127","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2013.10.061","volume":"257","author":"RW Gear","year":"2014","unstructured":"Gear RW, Bogen O, Ferrari LF, Green PG, Levine JD (2014) NOP receptor mediates anti-analgesia induced by agonist\u2013antagonist opioids. Neuroscience 257:139\u2013148","journal-title":"Neuroscience"},{"key":"3719_CR9","first-page":"547","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"H Gutstein","year":"2006","unstructured":"Gutstein H, Akil H (2006) Opioid analgesics. In: Brunton L, Lazo J, Parker K (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 547\u2013590","edition":"11"},{"key":"3719_CR10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","volume":"41","author":"PJ Hoskin","year":"1991","unstructured":"Hoskin PJ, Hanks GW (1991) Opioid agonist\u2013antagonist drugs in acute and chronic pain states. Drugs 41:326\u2013344","journal-title":"Drugs"},{"key":"3719_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1901\/jeab.1995.64-373","volume":"64","author":"SR Hursh","year":"1995","unstructured":"Hursh SR, Winger G (1995) Normalized demand for drugs and other reinforcers. J Exp Anal Behav 64:373\u2013384","journal-title":"J Exp Anal Behav"},{"key":"3719_CR12","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1523\/JNEUROSCI.0740-06.2006","volume":"26","author":"PJ Kenny","year":"2006","unstructured":"Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26:5894\u20135900","journal-title":"J Neurosci"},{"key":"3719_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00421261","volume":"42","author":"GF Koob","year":"1975","unstructured":"Koob GF, Spector NH, Meyerhoff JL (1975) Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat. Psychopharmacologia 42:231\u2013234","journal-title":"Psychopharmacologia"},{"key":"3719_CR14","first-page":"2473","volume":"38","author":"C Kornetsky","year":"1979","unstructured":"Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473\u20132476","journal-title":"Fed Proc"},{"key":"3719_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1979.01780030055004","volume":"36","author":"C Kornetsky","year":"1979","unstructured":"Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979) Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 36:289\u2013292","journal-title":"Arch Gen Psychiatry"},{"key":"3719_CR16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E (2002) Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710\u2013726","journal-title":"Nat Rev Drug Discov"},{"key":"3719_CR17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jm801272c","volume":"52","author":"G Li","year":"2009","unstructured":"Li G, Aschenbach LC, Chen J, Cassidy MP, Stevens DL, Gabra BH, Selley DE, Dewey WL, Westkaemper RB, Zhang Y (2009) Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. J Med Chem 52:1416\u20131427","journal-title":"J Med Chem"},{"issue":"1","key":"3719_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2004.06.006","volume":"79","author":"J Liu","year":"2004","unstructured":"Liu J, Schulteis G (2004) Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Pharmacol Biochem Behav 79(1):101\u2013108","journal-title":"Pharmacol Biochem Behav"},{"key":"3719_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/bk-2013-1131.ch009","volume-title":"Research and development of opioid-related ligands","author":"SS Negus","year":"2013","unstructured":"Negus SS, Altarifi A (2013) Mu, delta and kappa opioid agonist effects in novel assays of pain-depressed behavior. In: Ko H, Husbands SM (eds) Research and development of opioid-related ligands. American Chemical Society, Washington, DC, pp 163\u2013176"},{"key":"3719_CR20","doi-asserted-by":"crossref","first-page":"a012104","DOI":"10.1101\/cshperspect.a012104","volume":"3","author":"SS Negus","year":"2013","unstructured":"Negus SS, Banks ML (2013) Medications development for opioid abuse. Cold Spring Harb Perspect Med 3:a012104","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"3719_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","volume":"66","author":"SS Negus","year":"2014","unstructured":"Negus SS, Miller LL (2014) Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev 66(3):869\u2013917","journal-title":"Pharmacol Rev"},{"key":"3719_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00213-009-1770-6","volume":"210","author":"SS Negus","year":"2010","unstructured":"Negus SS, Morrissey EM, Rosenberg M, Cheng K, Rice KC (2010) Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) 210:149\u2013159","journal-title":"Psychopharmacology (Berl)"},{"key":"3719_CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/jpet.111.186783","volume":"340","author":"SS Negus","year":"2012","unstructured":"Negus SS, O\u2019Connell R, Morrissey E, Cheng K, Rice KC (2012a) Effects of peripherally restricted kappa opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J Pharmacol Exp Ther 340:501\u2013509","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpain.2011.12.003","volume":"13","author":"SS Negus","year":"2012","unstructured":"Negus SS, Rosenberg MB, Altarifi AA, O\u2019Connell RH, Folk JE, Rice KC (2012b) Effects of the delta opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats. J Pain 13:317\u2013327","journal-title":"J Pain"},{"key":"3719_CR25","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/jm061327z","volume":"50","author":"X Peng","year":"2007","unstructured":"Peng X, Knapp BI, Bidlack JM, Neumeyer JL (2007) Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors. J Med Chem 50:2254\u20132258","journal-title":"J Med Chem"},{"key":"3719_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2008.12.021","volume":"604","author":"G Pereira Do Carmo","year":"2009","unstructured":"Pereira Do Carmo G, Folk JE, Rice KC, Chartoff E, Carlezon WA Jr, Negus SS (2009) The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 604:58\u201365","journal-title":"Eur J Pharmacol"},{"key":"3719_CR27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","volume":"233","author":"A Pfeiffer","year":"1986","unstructured":"Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774\u2013776","journal-title":"Science"},{"key":"3719_CR28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3565(25)10897-5","volume":"262","author":"CG Pick","year":"1992","unstructured":"Pick CG, Paul D, Pasternak GW (1992) Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. J Pharmacol Exp Ther 262:1044\u20131050","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(91)90053-2","volume":"28","author":"KL Preston","year":"1991","unstructured":"Preston KL, Jasinski DR (1991) Abuse liability studies of opioid agonist-antagonists in humans. Drug Alcohol Depend 28:49\u201382","journal-title":"Drug Alcohol Depend"},{"key":"3719_CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","volume":"45","author":"K Raynor","year":"1994","unstructured":"Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330\u2013334","journal-title":"Mol Pharmacol"},{"key":"3719_CR31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3565(24)38026-7","volume":"288","author":"AE Remmers","year":"1999","unstructured":"Remmers AE, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F (1999) Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. J Pharmacol Exp Ther 288:827\u2013833","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3565(24)37462-2","volume":"285","author":"DE Selley","year":"1998","unstructured":"Selley DE, Liu Q, Childers SR (1998) Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496\u2013505","journal-title":"J Pharmacol Exp Ther"},{"key":"3719_CR33","first-page":"138","volume":"34","author":"GF Steinfels","year":"1981","unstructured":"Steinfels GF, Young GA, Khazan N (1981) The new mixed agonist\u2013antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats. NIDA Res Monogr 34:138\u2013144","journal-title":"NIDA Res Monogr"},{"key":"3719_CR34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-61779-313-4_19","volume-title":"Mood and anxiety related phenotypes in mice: characterization using behavioral tests, volume II. Neuromethods volume 63","author":"AK Stoker","year":"2011","unstructured":"Stoker AK, Markou A (2011) The intracranial self-stimulation procedure provides quantitative measures of brain reward function. In: Gould TD (ed) Mood and anxiety related phenotypes in mice: characterization using behavioral tests, volume II. Neuromethods volume 63. Humana, Totowa, pp 307\u2013331"},{"key":"3719_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","volume":"172","author":"MS Todtenkopf","year":"2004","unstructured":"Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr (2004) Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) 172:463\u2013470","journal-title":"Psychopharmacology (Berl)"},{"key":"3719_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-934-5_1","volume-title":"Animal models of drug addiction","author":"S Vlachou","year":"2011","unstructured":"Vlachou S, Markou A (2011) Intracranial self-stimulation. In: Olmstead MC (ed) Animal models of drug addiction. Humana, New York, pp 3\u201356"},{"key":"3719_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","volume":"157","author":"SL Walsh","year":"2001","unstructured":"Walsh SL, Strain EC, Abreu ME, Bigelow GE (2001) Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157:151\u2013162","journal-title":"Psychopharmacology (Berl)"},{"key":"3719_CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/105504999305965","volume":"8","author":"JD Wines Jr","year":"1999","unstructured":"Wines JD Jr, Gruber AJ, Pope HG Jr, Lukas SE (1999) Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addict 8:161\u2013164","journal-title":"Am J Addict"},{"key":"3719_CR39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","volume":"19","author":"RA Wise","year":"1996","unstructured":"Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319\u2013340","journal-title":"Annu Rev Neurosci"},{"key":"3719_CR40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/cn2000348","volume":"2","author":"Y Yuan","year":"2011","unstructured":"Yuan Y, Li G, He H, Stevens DL, Kozak P, Scoggins KL, Mitra P, Gerk PM, Selley DE, Dewey WL, Zhang Y (2011) Characterization of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists. ACS Chem Neurosci 2:346\u2013351","journal-title":"ACS Chem Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3719-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-014-3719-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-014-3719-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T12:28:58Z","timestamp":1746361738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-014-3719-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3719"],"URL":"https:\/\/doi.org\/10.1007\/s00213-014-3719-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}